Viewpoint
Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines

https://doi.org/10.1016/0165-6147(93)90005-5Get rights and content

Abstract

NMDA and non-NMDA (AMPA/kainate) antagonists have potential in the treatment of a diverse group of neurological disorders associated with excessive activation of excitatory amino acid receptors. Here Michael Rogawski reviews recent progress in the development of therapeutically useful NMDA receptor channel blockers and a new class of selective AMPA/ kainate receptor antagonists, the 2,3-benzodiazepines. Research on these novel noncompetitive excitatory amino acid antagonists has opened promising new avenues for the development of drugs to treat epilepsy, ischaemia, neuro-degeneration and Parkinson's disease.

References (60)

  • D.W. Choi

    Prog. Brain. Res.

    (1993)
  • J.A. Kemp et al.

    Trends Pharmacol. Sci.

    (1993)
  • J.D. Leander et al.

    Brain Res.

    (1988)
  • R. Netzer et al.

    Eur. J. Pharmacol.

    (1993)
  • M.L. Stagnitto

    Epilepsy Res.

    (1990)
  • K. Masuo et al.

    Eur. J. Pharmacol.

    (1986)
  • G. Reiser et al.

    Brain Res.

    (1988)
  • M. Bubser et al.

    Eur. J. Pharmacol.

    (1992)
  • P. Riederer et al.

    Lancet

    (1991)
  • J.C. Watkins et al.

    Trends Neurosci.

    (1990)
  • A.G. Chapman et al.

    Neurosci. Lett.

    (1985)
  • L. Turski et al.

    Eur. J. Pharmacol.

    (1987)
  • H. Jackson et al.

    Trends Neurosci.

    (1988)
  • S. Herlitze

    Neuron

    (1993)
  • Z. Miljkovic et al.

    Brain Res.

    (1986)
  • S. Pellow et al.

    Neurosci. Biobehav. Rev.

    (1986)
  • C. Salamon et al.

    FEES Lett.

    (1992)
  • I. Tarnawa et al.

    Eur. J. Pharmacol.

    (1989)
  • S.D. Donevan et al.

    Neuron

    (1993)
  • C.F. Zorumski et al.

    Neuron

    (1993)
  • A.G. Chapman et al.

    Epilepsy Res.

    (1991)
  • S.E. Smith et al.

    Eur. J. Pharmacol.

    (1991)
  • I. Tarnawa

    Bioorg. Med. Chem. Lett.

    (1993)
  • M.A. Rogawski

    Drugs

    (1992)
  • J.F. MacDonald

    J. Physiol. (Lond.)

    (1991)
  • J.H. Krystal

    Soc. Neurosci. Abst.

    (1992)
  • L. Iversen

    Ann. New York Acad. Sci.

    (1992)
  • P.A. Blake et al.

    Epilepsia

    (1992)
  • M.A. Rogawski

    J. Pharmacol. Exp. Ther.

    (1991)
  • Cited by (0)

    View full text